Lupin gets US FDA nod for Febuxostat tablets EP News Bureau Jan 18, 2024 Febuxostat Tablets, 40 mg and 80 mg, are indicated for the chronic management of hyperuricemia in adult patients with gout who…
USFDA approves Febuxostat tablets by Zydus EP News Bureau Jan 10, 2023 The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Dr Reddy’s Laboratories launches Febuxostat Tablets in US EP News Bureau Jan 11, 2021 They are used to treat gout, which is associated with an excess of a chemical called uric acid (urate) in the body
Indoco receives approval for Febuxostat Tablets from US FDA EP News Bureau Dec 31, 2019 The market size of Febuxostat Tablets in USA is over USD 500 million
Alembic Pharma gets USFDA nod for Febuxostat tablets EP News Bureau Jul 2, 2019 The approved product is therapeutically equivalent to the reference listed drug Uloric tablets of Takeda Pharmaceuticals